Frankfurt - Delayed Quote EUR
Actinium Pharmaceuticals, Inc. (7AY1.F)
1.1160
-0.0830
(-6.92%)
As of 8:02:51 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 5 |
| Avg. Estimate | -- | 8.9M | -- | 9.29M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | 35.62M | -- | 35M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 7AY1.F | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/25/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/20/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/18/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |